Scientists track experimental cancer Drug's journey through the body
NCT ID NCT06713369
Summary
This early-stage study aims to understand how the body absorbs, uses, and eliminates the experimental drug Saruparib in patients with advanced solid tumors. Eight participants will stay in a hospital to receive the drug orally and intravenously while researchers collect blood, urine, and stool samples to track the drug's path. The main goal is to gather detailed information about how the drug moves through the body, not to test its effectiveness against cancer.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for LOCALLY ADVANCED OR METASTATIC SOLID TUMOR are added.
Genom att skicka in godkänner du våra Användarvillkor
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
Genom att skicka in godkänner du våra Användarvillkor
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
Research Site
RECRUITINGLiverpool, L7 8YA, United Kingdom
-
Research Site
RECRUITINGManchester, M20 4BX, United Kingdom
Conditions
Explore the condition pages connected to this study.